Kimelman & Baird LLC cut its position in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 31.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,850 shares of the company’s stock after selling 2,250 shares during the quarter. Kimelman & Baird LLC’s holdings in Kimberly-Clark were worth $636,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Park Avenue Securities LLC grew its holdings in shares of Kimberly-Clark by 77.4% during the fourth quarter. Park Avenue Securities LLC now owns 13,786 shares of the company’s stock worth $1,807,000 after buying an additional 6,016 shares in the last quarter. Pensionfund Sabic grew its holdings in shares of Kimberly-Clark by 45.5% during the fourth quarter. Pensionfund Sabic now owns 12,800 shares of the company’s stock worth $1,677,000 after buying an additional 4,000 shares in the last quarter. Barclays PLC grew its holdings in shares of Kimberly-Clark by 19.4% during the third quarter. Barclays PLC now owns 1,681,671 shares of the company’s stock worth $239,267,000 after buying an additional 273,813 shares in the last quarter. Aprio Wealth Management LLC grew its holdings in shares of Kimberly-Clark by 20.0% during the fourth quarter. Aprio Wealth Management LLC now owns 2,792 shares of the company’s stock worth $366,000 after buying an additional 466 shares in the last quarter. Finally, West Oak Capital LLC grew its holdings in shares of Kimberly-Clark by 20,377.6% during the fourth quarter. West Oak Capital LLC now owns 33,788 shares of the company’s stock worth $4,428,000 after buying an additional 33,623 shares in the last quarter. 76.29% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, VP Andrew Drexler sold 10,838 shares of Kimberly-Clark stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $141.00, for a total transaction of $1,528,158.00. Following the completion of the sale, the vice president now directly owns 7,720 shares of the company’s stock, valued at approximately $1,088,520. This trade represents a 58.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.62% of the stock is currently owned by insiders.
Kimberly-Clark Stock Performance
Kimberly-Clark (NYSE:KMB – Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The company reported $1.50 earnings per share for the quarter, hitting the consensus estimate of $1.50. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. On average, equities research analysts expect that Kimberly-Clark Co. will post 7.5 earnings per share for the current year.
Kimberly-Clark Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 2nd. Investors of record on Friday, March 7th will be issued a dividend of $1.26 per share. This is a boost from Kimberly-Clark’s previous quarterly dividend of $1.22. This represents a $5.04 annualized dividend and a yield of 3.61%. The ex-dividend date is Friday, March 7th. Kimberly-Clark’s dividend payout ratio (DPR) is presently 66.75%.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. Royal Bank of Canada reiterated an “outperform” rating and set a $165.00 price objective on shares of Kimberly-Clark in a report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and set a $158.00 price target (down from $161.00) on shares of Kimberly-Clark in a research report on Wednesday, January 29th. Wells Fargo & Company reduced their price target on Kimberly-Clark from $140.00 to $130.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 7th. JPMorgan Chase & Co. reduced their price target on Kimberly-Clark from $140.00 to $124.00 and set an “underweight” rating for the company in a research report on Thursday, January 16th. Finally, TD Cowen cut Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 price target for the company. in a research report on Wednesday, January 8th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $143.64.
Read Our Latest Stock Analysis on KMB
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
- Five stocks we like better than Kimberly-Clark
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- How to Build the Ultimate Everything ETF Portfolio
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Growth Stocks: What They Are, Examples and How to Invest
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.